Contributions of Toxicology to the Problem of Chagas' Disease (American Trypanosomiasis) - A Year 2000 Update

Biomedical and Environmental Sciences

Volumn 13, Issue 4, 2000, Pages 271-279

  Castro, José Alberto ^a  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITRYPANOSOMAL AGENT; BENZNIDAZOLE; CRYSTAL VIOLET; NIFURTIMOX; NITROIMIDAZOLE DERIVATIVE;

ANIMAL; CHAGAS DISEASE; DISEASE CARRIER; DRUG EFFECT; HUMAN; METHODOLOGY; PARASITOLOGY; REVIEW; TOXICOLOGY;

ANIMALS; CHAGAS DISEASE; GENTIAN VIOLET; HUMANS; INSECT VECTORS; NIFURTIMOX; NITROIMIDAZOLES; TOXICOLOGY; TRYPANOCIDAL AGENTS;

EID: 0034571615     PISSN: 08953988     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. 14C-DDT in Triatoma infestans. J. Econ. Entomol. 57, 974-977.
2. Aguilar, E. G., Arranz, C. K. de, Toranzo, E. G. D. de, and Castro, J. A. (1985) . Benznidazole and Nifurtimox nitroreductase activity in liver microsomes from male rats preinduced with phenobarbital or 3-methylcholanthrene. Res. Commun. Chem. Pathol. Pharmacol. 50, 443-446.
3. Aguilar, E. G., Koldobsky, C., Toranzo, E. G. D., and Castro, J. A. (1987). Species and sex differences in the liver microsomal nitroreductase biotransformation of Nifurtimox and Benznidazole. Arch . Int. Pharmacodyn. Ther. 287, 181-187.
4. Aguilar, E. G., Toranzo, E. G. D. de, and Castro, J. A. (1990). Pasaje del antichagásico Benznidazol vía leche materna a ratas lactantes. Efectos sobre el metabolismo de xenobióticos. Acta. Bioq. Clin. Latinoam. 24, 371-374.
5. Alzogaray, R. and Zerba, E. N. (1996) . Comparative toxicity of deltamethrin and cis-permethrin in first instar of Triatoma infestans. J. Med. Entomol. 33, 58-62.
6. Alzoagaray, R., Picollo, M. I., and Zerba, E. N. (1998). Independent and joint action of cis and trans permethrin on Triatoma infestans hemipater Reduvidae. Arch. Insect. Biochem. Physiol. 37, 225-230.
7. Bernacchi, A. S., Castro, C. R. de, Toranzo, E. G. D. de, and Castro, J. A., (1986). Effect of Nifurtimox or Benznidazole administration on rat testes: Ultrastructural observations and biochemical studies. Exp. Mol. Pathot. 45, 245-256.
8. Brener, Z. (1979), Present status of chemotherapy and chemoprophylaxis of human trypanosomiasis in the western hemisphere . Pharmaeol. Ther. 7, 71-90.
9. Casabe, N., Melgar, F., Wood, E., and Zerba, E. (1988). Insecticide action of pyrethroids in Triatoma infestants. Insec. Sci. Appl. 9, 233-236.
10. Castro, C. R. de, Toranzo E. G. D. de, and Castro, J. A. (1992). Benznidazole-induced ultrastructural alterations in rat adrenal cortex. Toxicology 74, 223-232.
11. Castro, C. R. de, Toranzo, E. G. D. de, Bernacchi, A. S., Carbone, M., and Castro, J. A. (1989), Ultrastructural alterations in ovaries from Nifurtimox or Benznidazole-treated rats. Their relation to ovarian nitroreductive biotransformation of both drugs. Exptl. Mol. Pathol. 50, 385-397.
12. Castro, C. R. de, Toranzo, E. G. D. de, Carbone. M., and Castro, J. A. (1990). Ultrastructural effects of Nifurtimox on rat adrenal cortex related to reductive biotransformation. Exp. Mol. Pathol. 52, 98-108.
13. Castro, G. D., López, A. J., and Castro, J. A. (1988). Evidence for hydroxyl free radical formation during Paraquat but not for Nifurtimox liver microsomal biotransformation. A dimethyl-sulfoxide scavening study. Arch. Toxicol. 62, 358.
14. Castro, J. A. and Toranzo, E. G. D. de (1988). Toxic effects of Nifurtimox and Benznidazole. Two drugs used against American Trypanosomiasis (Chagas' disease). Biomed. Environ. Sci. l, 19-33.
15. Castro, J. A., Zerba, E., Licastro, S. de, Picollo, M. I., Wood, E., Ruveda, M., Moutier Aldao, E. M. de, and Libertella, R. (1976) . Toxicity of methyl bromide and other gaseous insecticides to Triatoma infestans. Acta Physiol. Latinoam. 26, 106-114.
16. Celentano, A. M. and Gonzalez Cappa, S. M. (1988). Enfermedad de Chagas y transfusión sanguínea: actividad trypanqcida del clorhidrato de maprotilina y del Violeta de Genciana. Medicina (Buenos Aires) 48, 265-268.
17. Cerisola, J. A., Rabinovich, A., Alvarez, M., de Corletto, C. H., and Pruneda, J. (1972). Enfermedad de Chagas y la transfusión de sangre. Boll. Sanit. Panam. 73, 203.
18. Chaves Olivera, E., Brasil Leite, M., Luguetti Ostermayer, A., Caetano Almeida, A., and Moreira, H. (1997). Chagasic megacolon associated with colon cancer. Am. J. Trop. Med. Hyg. 56, 596-598.
19. De Castro, S. L. (1993). The challenge of Chagas' disease chemotherapy: An update of drugs assayed against Trypanosoma cruzi. Acta Tropica 53, 83-98.
20. Diaz, E. G. D., Rodriguez de Castro, C., Montalto De Mecca, M., and Castro, J. A. (2000) . Benznidazole- induced ultrastructural and biochemical alterations in the rat colon. Acta Pharmacologica Sinica (in press).
21. Docampo. R. and Moreno, S. N. (1985). Biochemical toxicology of antiparasitic compounds used in the chemothera- phy and chemoprophylaxis of American Trypanosomiasis (Chagas' disease). Rev. Biochem. Toxicol. 7, 159-204.
22. Docampo, R. and Moreno, S. N. J. (1990) . The metabolism and mode of action of Gentian Violet. Drug Met. Rev. 22, 161-178.
23. Fairlamb, A. (1982). Biochemistry of trypanosomiasis and rational approaches to chemotheraphy. Trends. Biochem. Sci. July, 249-253.
24. Ferreyra, R. C. C. and Ferreyra, L. C. S. (1968). Mutagenicity of Nifurtimox and Benznidazole in the Salmonella/microsome assay, Braz. J. Med. Biol. Res. 19, 19-25.
25. Fontan, A. and Zerba, E. (1992). Influence of the nutritional state of Triatoma infestans over the insecticidal activity of DDT. Comp. Biochem. and Physiol. 101c(3), 589-591.
26. Franke de Cazzulo, B. M., Bernacehi, A. S., Esteva, M., Ruiz, A. M., Castro, J. A., and Cazzulo, J. J . (1998). Trypanocidal effect of B-diethylaminoethyl-diphenyl propyl acetate hydrochloride (SKF 525A; Proadifen). On different developmental forms of Trypanosoma cruzi. Medicina 58, 415-418.
27. Gorla, N. B. and Castro, J. A. (1985). Micronucleus formation in bone marrow of mice treated with Nifurtimox or Benznidazole. Toxicol. Lett. 25, 259-263.
28. Gorla, N. B., Díaz Gómez, M. I., and Castro, J. A. (1986). Interaction of Benznidazole reactive metabolites with rat liver deoxyribonucleic acid and nuclear proteins. Arch. Int. Pharmacodyn. Ther. 280, 22-31.
29. Gorla, N. B., Ledesma, O. S., Barbieri, G., and Larripa, I. B. (1988). Assessment of cytogenetic damage in chagasic children treated with Benznidazole. Mut. Res. 206, 212-220.
30. Gorla, N. B., Ledesma, O. S., Barbieri, G., and Larripa, I. B. (1989). Thirteefold increase of chromosomal aberrations non-randomly distributed in Chagasic children treated with Nifurtimox. Mut. Res. 224, 263-267.
31. Krauth-Siegel, R. L., and Schöneck, R. (1995). Trypanothione reductase and lipoamide dehydrogenase as targets for a structure-based drug design. FASEB J. 9, 1138-1146.
32. Lacuara, J. L., Barioglio, S. R. de, Oliva, P. P., Bernacehi, A. S., Culasso, A. F. de, Castro. J. A., Cazzulo, B. M. F., de and Cazzulo, J. J. (1991). Disruption of mitochondrial function as the basis of the trypanocidal effect of trifluoperazine on Trypanosoma cruzi. Experientia 47, 612-616.
33. Lustig, E. S. de, Puricelli, L., Bal, E., and Lansetti, J. C. (1980). Asociación entre la enfermedad de Chagas y el cáncer. Medicina 40, 43-48.
34. Masana, M., Toranzo, E. G. D., and Castro, J. A. (1984). Reductive metabolism and activation of Benznidazole. Biochem. Pharmacol. 33, 1041-1045.
35. Masana, M., Toranzo, E. G. D., and Castro, J. A. (1984). Studies on Nifurtimox nitroreductase activity in liver and other rat tissues. Arch. Int. Pharmacodyn. Ther. 270, 4-10.
36. Masana, M., Toranzo, E. G. D., Rubio, M., and Castro, J. A. (1985). Effect of benznidazole on the mixed function oxygenase system from rat liver microsomes. Arch. Int. Pharmacodyn. Ther. 276; 4-11.
37. Montalto de Mecca, M., de Castro, C. R., Diaz, E. G. D., and Castro, J. A. (2000a). Alteraciones ultra-estructurales en la mucosa del colon de ratas tratadas con nifurtimox. Medicina, in press.
38. Montalto de Mecca, M., Bernacchi, A. S., and Castro, J. A. (2000b). Prevention of Benznidazoleinduced prolonging effect on the pentobarbital sleeping time of rats using different thiolcontaining compounds. Res. Commun. Mol. Pathol. Pharmacol (in press).
39. Nagel, R. and Nepomnaschy, I. (1983). Mutagenicity of 2-antichagasic drugs and their metabolic deactivation. Mut. Res. 117, 237-242.
40. Navairo, M. L. and Nagel, R. (1984a). Sperm head abnormalities in mice induced by two antichagasic drugs. Comun. Biol. 3, 29-32.
41. Navarro, M. L., Dain, L., Migliorini, A. M., and Nagel, R. (1984b). Clastogenic activity of two antichagasic drugs. Comun. Biol. 3, 25-28.
42. Ohnishi, T. Ohashi, Y., Nozu, K., and Inoki, S. (1980). Mutagenicity of Nifurtimox in Escherichia coli. Mut. Res. 77, 241-244.
43. Ohnishi, T., Ohashi, Y., Nozu, K., and Inoki, S. (1983). Mutagenicity of anti-trypanosomal drug. Ro7-1051, in Escherichi coli. Japan J. Genet. 58, 505-509.
44. Picollo de Villar, K., Zerba, K., Wood, K., and Licastro, S. de. (1980). Neurogenesis and occurrence of cholinesterase in eggs of Triatoma infestans. Comp. Biochem. Physiol. 65c, 65-69.
45. Picollo de Villar, M. I., Seccacini, F., Fontun, A., and Zerba, E. (1987). Activity of insect growth regulator Fenoxycarb (RO-B-5223) on Triatoma infestans. Comp. Biochem. Physiol. 87c, 367-373.
46. Picollo, M. I., Seocacini, E., Vassena, C., and Zerba, E. (1993). Feeding and mating deterrency by sulfhydryl reagents in Triatoma infestans. Acta Tropica 52, 297-307.
47. Pinchin , R., Oliveira Filho, A., and Pereira, A. C. (1976) . The flushing out activity of pyrethrum and syntheth- ic pyrethroids on Pastronglylus megistus, a vector of Chagas' Disease. Trans. Roy. Soc. Trop. Med. Hyg. 74, 801-803.
48. Pinto Díaz, J. C. (1984). Enfermedad de Chagas', Epidemiología, Clínica, Terapéutica, pp 1-106. Programa de Salud Humana, Buenos Aires.
49. Ponce, C. (1999) . La enfennedad de Chagas transfusional en Honduras y otros países de América Central. Medici- na (Buenos Aires) 59, Suppl, II, 135-137.
50. Schirmer, R. H., Muller, J. G., and Krauthsiegel, R. L. (1995). Disulfide-reductase inhibitors as chemotherapeutic agents: The design of drugs for Trypanosomiasis and Malaria. Angew. Chem. Int. Ed. Engl. 34, 141-154.
51. Schmun∼is, G. A. (1991) . Trypanosoma cruzi, the etiologic agent of Chagas disease: status in the blood supply in endemic and non endemic countries. Transfusion 31, 547-557.
52. Schmunis, G. A. (1999). Riesgo de la enfermedad de Chagas a través de las transfusiones en las Américas. Medicina (Buenos Aires) 59, Suppl. II, 125-134.
53. Sosa Estani, S. and Segura, E. L. (1999). Tratamiento de la infectión por Trypanosoma cruzi en fase indetermina-da. Experieucia y normatización actual en Argentina. Medicina (Buenos Aires) 59, Suppl. II, 166-170.
54. Spano, M. A. and Takahashi, C. S. (1981). Genetic effects of Nifurtimox on Drosophila melanogaster, Wistar rats and Album cepa. Rev. Brasil Genet. 3, 357-366.
55. Stoppani, A. O. M. (1999). Quimioterapia de la enfermedad de Chagas. Medicina 59, Suppl. II, 147-165.
56. Teixeira, A. R. L., Calixto, M. A., and Teixeira, M. L. (1994). Chagas' disease: carcinogenic activity of the antitrypanosomal nitroarenes in mice. Mut. Res. 305, 189-196.
57. Toranzo, E. G. D. de, Castro, J. A., Franke de Cazzulo, and Cazzulo, J. J. (1988) . Interaction of benznidazol reactive metabolites with nuclear and kinetoplastic DNA, proteins and lipids from Trypanosoma cruzi. Experientia 44, 880-881.
58. Toranzo, E. G. D. de, Masana, M., and Castro, J. A. (1983). Nitroreduction of Benznidazole and Nifurtimoxby rat or human feces . Res. Commun. Chem. Pathol. Pharmacol. 41, 341-344.
59. Toranzo, E. G. D. de, Masana, M., and Castro, J. A. (1984). Administration of Benznidazole, a chemothera- peutic agent against Chagas' disease to pregnant rats. Covalent binding of reactive metabolites to fetal and maternal proteins. Arch. Int. Pharmacodyn. Ther. 272, 17-23.
60. Toranzo, F. G. D. de, Herrera, D. M., and Castro, J. A. (1997). Rat liver nuclear nifurtimox nitroreductase activity. Research Communications in Molecular Pathology 98, N°3, 249-254.
61. Vassena, C., Picollo, M. I., and Zerba, E. N. (1996). Reduction of Triatoma infestans experimental populations exposed to feeding inhibitions. J. Med. Entomol. 33, 823-827.
62. Wallace, G., Zerba, E., Wood, F., Casabe, N., Martínez, A . , Hurvitz, A., Andres, A., Vaez, R., andVigil, E. (1993). Ensayo de campo de asimetrina, un nuevo piretroide de alto efecto triatomicida. Medicina53, Suppl. I, 74.
63. Wood, E., Licastro, S. de, Casabe, N., Sivori, J., and Zerba, E. (1993a). Evaluation of the flushing out activity of pyrethroids on Triatoma infestans. Insect Sci. Applic. 14(5), 651-655.
64. Wood, F., Picollo de Villar, M. I., and Zerba, E. (1993b). Comparaoión entre la variación de la capacidaddetoxificante y la diferente susceptibilidad al insecticida malatión entre ninfas V de distinta edad de Triatoma infestants. An. Asoc. Quím. Arg. 81, 153-162.
65. World Health Organization (WHO) (1981). Workshop on guidelines for standarized protocols for the chemotheraphyof Chagas' disease. TDR/CHFMCHA/DCWKSHP/8/3, pp 1-12.
66. World Health Organization (WHO) (1985). Meeting on the development of trypanocydal compounds for the steriliza- tion of blood. TDR/CHA/BS 84: 3.
67. Zerba, E. (1989). Chemical control of Chagas' disease vectors. Biom. Environ. Sci. 2, 2-24.
68. Zerba, E. N. (1998). Insecticidal activity of pyrethroids on insects of medical importance. Parasital. Today 4, 53-
69. Zerba, E. N. (1999). Susceptibility and resistance to insecticides of Chagas" disease vectors. Medicinu (Buenos Aires) 59, Suppl. II, 41-46.